Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer
Status:
Completed
Trial end date:
2008-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness and safety of experimental
treatment matuzumab and ECX chemotherapy, with ECX chemotherapy. Participants invited to take
part have metastatic cancer of the esophagus (gullet) or stomach.